Riskpilot← Back to searchSign inGet full accessMORBUS CONSULTORUS AS
ASActiveOrg 919972068Seilduksgata 6A, 0553 OsloGeneral medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
NOK 0
EBITDA margin
—
-229% vs 2023
Equity ratio
-444.3%
Financial strength
Net profit 2024
NOK -5K
-311% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -5K | -229% |
| Net profit | NOK -5K | -311% |
| Total assets | NOK 4K | -85% |
| Equity | NOK -17K | -40% |
| Employees | 0 | — |
Legal name
MORBUS CONSULTORUS AS
Org number
919972068
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
6. desember 2017
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legetjenester, kurstjenester, og konsulenttjenester innen helse, it, forretningsutvikling og selskapsdrift.
Address
Seilduksgata 6A, 0553 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 134 | 78 | 23 | 1 | 14 | 15 | 0 |
| Staff expenses | −0 | −108 | −58 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −14 | −8 | −7 | −8 | −10 | 4 | −5 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −14 | −8 | −7 | −8 | −10 | 4 | −5 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 |
| Profit before tax | 0 | −14 | −8 | −7 | −8 | −10 | 2 | −5 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −14 | −8 | −7 | −8 | −10 | 2 | −5 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 31 | 37 | 18 | 11 | 14 | 17 | 26 | 4 |
| Equity | 31 | 17 | 10 | 3 | −5 | −14 | −12 | −17 |
| Long-term debt | 0 | 0 | 0 | 10 | 20 | 20 | 21 | 21 |
| Short-term debt | 0 | 20 | 8 | −2 | −1 | 11 | 17 | 0 |
| Total debt | 0 | 20 | 8 | 8 | 19 | 31 | 38 | 21 |
EBITDA margin
-485800.0%
This company
15.8%
Market median
-3074784% vs market
20172024
Equity ratio
-444.3%
This company
38.2%
Market median
-1263% vs market
20172024
Return on equity
-485400.0%
This company
18.4%
Market median
-2638143% vs market
20172024
Net profit margin
-485400.0%
This company
8.1%
Market median
-5992693% vs market
20172024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PK Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MORBUS CONSULTORUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petter Kirkeby Risøe | Chief Executive Officer | 0 companies |